medindia
  1. Medindia
  2. Health Tips and Quotations

Potential Therapeutic Target for Diabetes

A sirtuin enzyme (Sirt2) has been identified as a key player in regulating hepatic glucokinase or hepatic glucose uptake (HGU) through modifying glucokinase regulatory protein (GKRP), suggesting that this mechanism offers a potential therapeutic target for type 2 diabetes.

Sirtuin Enzyme - Potential Therapeutic Target for Diabetes - Sirtuin enzyme (sirt2) may be the key cause in hepatic glucokinase - It may be a potential therapeutic target in type-2 diabetes treatment

Potential Therapeutic Target for Diabetes - Sirtuin Enzyme

Sirtuin enzyme (Sirt2) may be a key player in regulating hepatic glucokinase and a potential therapeutic target for type 2 diabetes. Read More

Related Links

Slim Down Naturally With Ash Gourd Juice
Do You Get Drowsy At Work After Having Lunch?
Eating Right at Night: Choosing the Best Foods for Evening Health
Menopause and Heart Health: Protecting Your Cardiovascular Wellness
Savor Strawberries Everyday to Keep Dementia at Bay
High-Protein Breakfast: Your Path to Body Fat Loss
Why Does Foot Swelling Occur While Flying?
Mood Foods: What to Eat and What to Avoid for Better Mental Health
Men's Health Signals You Should Not Ignore
Top 5 Everyday Habits That Affect Your Vision
Harness the Healing Power of Avocado Seed Tea
Nutritional Guide to Staying Healthy During the Monsoon Season

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024